These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute. Moon YW, Jeung HC, Rha SY, Yoo NC, Roh JK, Noh SH, Kim BS, Chung HC. Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757 [Abstract] [Full Text] [Related]
5. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer. Ikeguchi M, Ohfuji S, Oka A, Tsujitani S, Maeda M, Kaibara N. Hepatogastroenterology; 1995 Oct; 42(5):672-6. PubMed ID: 8751233 [Abstract] [Full Text] [Related]
6. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Chipponi J, Huguier M, Pezet D, Basso N, Hay JM, Quandalle P, Jaeck D, Fagniez PL, Gainant A. Am J Surg; 2004 Mar; 187(3):440-5. PubMed ID: 15006580 [Abstract] [Full Text] [Related]
7. Role of surgery in the patients with stage I and II primary gastric lymphoma. Takahashi I, Maehara Y, Koga T, Sumiyoshi Y, Oshiro T, Baba H, Kohnoe S, Okamura T, Uike N, Matsusaka T, Kume K, Sugimachi K. Hepatogastroenterology; 2003 Mar; 50(51):877-82. PubMed ID: 12828109 [Abstract] [Full Text] [Related]
8. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. Nashimoto A, Nakajima T, Furukawa H, Kitamura M, Kinoshita T, Yamamura Y, Sasako M, Kunii Y, Motohashi H, Yamamoto S, Gastric Cancer Surgical Study Group, Japan Clinical Oncology Group. J Clin Oncol; 2003 Jun 15; 21(12):2282-7. PubMed ID: 12805327 [Abstract] [Full Text] [Related]
9. [Secondary malignancies after gastrectomy for gastric cancer]. Niimoto M, Hirono M, Hattori T, Nakajima T, Hirata K, Iwanaga T, Kimura T, Nakazato H, Inokuchi K, Sugimachi K. Gan To Kagaku Ryoho; 1986 Apr 15; 13(4 Pt 2):1475-83. PubMed ID: 3729464 [Abstract] [Full Text] [Related]
10. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Smith RE, Colangelo L, Wieand HS, Begovic M, Wolmark N. J Natl Cancer Inst; 2004 Aug 04; 96(15):1128-32. PubMed ID: 15292384 [Abstract] [Full Text] [Related]
14. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy. Díez M, Medrano MJ, Gutierrez A, López A, Mugüerza JM, Hernández P, Lozano O, Noguerales F, Ruíz A, Granell J. Anticancer Res; 2000 Aug 04; 20(5C):3929-33. PubMed ID: 11268479 [Abstract] [Full Text] [Related]
15. Clinical profile of carcinoma stomach at a tertiary care hospital in south India. Sambasivaiah K, Ibrarullah M, Reddy MK, Reddy PV, Wagholikar G, Jaiman S, Reddy DG, Sarma KV, Hegde GN. Trop Gastroenterol; 2004 Aug 04; 25(1):21-6. PubMed ID: 15303466 [Abstract] [Full Text] [Related]
16. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany]. Bösing NM, Heise JW, Röher HD. Zentralbl Chir; 2000 Aug 04; 125(4):341-7. PubMed ID: 10829314 [Abstract] [Full Text] [Related]
17. Results of immunochemo-surgery for gastric carcinoma. Kim JP, Yu HJ, Lee JH. Hepatogastroenterology; 2001 Aug 04; 48(41):1227-30. PubMed ID: 11677936 [Abstract] [Full Text] [Related]
18. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. Matsubara T, Yamada K, Nakagawa A. J Clin Oncol; 2003 Dec 01; 21(23):4336-41. PubMed ID: 14645422 [Abstract] [Full Text] [Related]
19. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. Aldrighetti L, Castoldi R, Di Palo S, Arru M, Stella M, Orsenigo E, Gavazzi F, Ferla G, Di Carlo V, Staudacher C. Chir Ital; 2005 Dec 01; 57(5):555-70. PubMed ID: 16241086 [Abstract] [Full Text] [Related]
20. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):786-96. PubMed ID: 14967435 [Abstract] [Full Text] [Related] Page: [Next] [New Search]